GLEOLAN DIN 02504928
Health Canada record
| Active ingredient(s) | AMINOLEVULINIC ACID HYDROCHLORIDE 1.5 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XD04 AMINOLEVULINIC ACID |
| Original market date | 22-Feb-2021 |
| Current status date | 22-Feb-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Medexus Pharmaceuticals Inc. — licence 101526, currently licensed, last inspection rating C (2026-02-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMINOLEVULINIC ACID HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02243933 | LEVULAN KERASTICK | SUN PHARMACEUTICAL INDUSTRIES, INC. | Powder For Solution | AMINOLEVULINIC ACID HYDROCHLORIDE 20 % | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24192 | 2020-09-09 | New Drug Submission (NDS) |
International API supply for AMINOLEVULINIC ACID HYDROCHLORIDE
3 active FDA Drug Master Files.
Request a quote for GLEOLAN